Fig. 6: Estimating the optimal measles-containing vaccine dose 1 (MCV1) age in high-burden scenarios.
From: Estimating the optimal age for infant measles vaccination
a Estimated annual incidence when recommending MCV1 at ages 6–20 months, with 45% MCV1 coverage. Each line indicates the relative incidence for a given parameter set relative to the minimum incidence for that parameter set. b Heatmap of optimal ages. Opacity indicates the proportion of parameter sets with an optimum at a given MCV1 age. For clarity, the 55% and 75% MCV1 coverage results are not displayed. c Mean annual incidence per 100,000 at the optimal MCV1 age by demographic type for different MCV1 coverage. Points indicate the mean incidence, and lines indicate the 2.5% and 97.5% quantiles.
